Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pomalidomide”

266 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 266 results

Testing effectiveness (Phase 2)WithdrawnNCT02228512
What this trial is testing

Study of Pomalidomide Combined With Modified DA-EPOCH and Rituximab in KSHV-Associated Lymphomas

Who this might be right for
Large Cell Lymphoma Arising in KSHV-associated Multicentric Castleman DiseasePrimary Effusion Lymphoma
National Cancer Institute (NCI)
Post-approval studies (Phase 4)Study completedNCT05555329
What this trial is testing

Alternative Dosing Scheme of Pomalidomide 4 mg Every Other Day Versus Pomalidomide 2 mg and 4 mg Every Day; the POMAlternative Study

Who this might be right for
Multiple Myeloma in RelapseMultiple MyelomaMultiple Myeloma, Refractory
Amsterdam UMC, location VUmc 12
Testing effectiveness (Phase 2)Ended earlyNCT01997840
What this trial is testing

ACY-1215 (Ricolinostat) in Combination With Pomalidomide and Low-dose Dex in Relapsed-and-Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Celgene 103
Testing effectiveness (Phase 2)Study completedNCT01745640
What this trial is testing

Pomalidomide and Dexamethasone Effects in Multiple Myeloma Patients With Del 17p or t (4;14)

Who this might be right for
Multiple Myeloma
University Hospital, Lille 63
Testing effectiveness (Phase 2)Study completedNCT03731832
What this trial is testing

Pomalidomide, Ixazomib, and Dexamethasone With or Without Intensification by Cyclophosphamide in Relapsed or Refractory Multiple Myeloma

Who this might be right for
Refractory Multiple Myeloma
GWT-TUD GmbH 66
Testing effectiveness (Phase 2)Study completedNCT02963493
What this trial is testing

Melphalan Flufenamide (Melflufen) Plus Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Oncopeptides AB 157
Not applicableNot Yet RecruitingNCT07637526
What this trial is testing

Study to Evaluate Efficacy and Safety of Belantamab-based Combinations for Relapsed Multiple Myeloma

Who this might be right for
Relapse Multiple Myeloma
PETHEMA Foundation 100
Early research (Phase 1)Looking for participantsNCT04902443
What this trial is testing

Pomalidomide and Nivolumab in People With Virus-Associated Malignancies With or Without HIV

Who this might be right for
Viral Associated MalignanciesKaposi SarcomaEBV/KSHV-associated Lymphomas
National Cancer Institute (NCI) 58
Large-scale testing (Phase 3)Looking for participantsNCT05519085
What this trial is testing

Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)

Who this might be right for
Relapsed or Refractory Multiple Myeloma
Celgene 810
Testing effectiveness (Phase 2)Looking for participantsNCT06342466
What this trial is testing

Bortezomib, Pomalidomide, Dexamethasone for Systemic AL Amyloidosis

Who this might be right for
Systemic Amyloidosis
Jin Lu, MD 40
Large-scale testing (Phase 3)Looking for participantsNCT06152575
What this trial is testing

MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)

Who this might be right for
Multiple Myeloma
Pfizer 492
Testing effectiveness (Phase 2)UnknownNCT04287855
What this trial is testing

Multicenter Open Label Phase 2 Study of Isatuximab Plus Pomalidomide and Dexamethasone With Carfilzomib in Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma in RelapseMultiple Myeloma, Refractory
Poitiers University Hospital 82
Testing effectiveness (Phase 2)Study completedNCT01794039
What this trial is testing

Pomalidomide or Lenalidomide and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma Previously Treated With Lenalidomide

Who this might be right for
Recurrent Plasma Cell MyelomaRefractory Plasma Cell Myeloma
Mayo Clinic 9
Testing effectiveness (Phase 2)Active Not RecruitingNCT07150104
What this trial is testing

Sub-study of Belantamab Mafodotin (GSK2857916) as Monotherapy and in Combination With Nirogacestat, Pomalidomide, and Dexamethasone in Participants With RRMM

Who this might be right for
Multiple Myeloma
GlaxoSmithKline 14
Testing effectiveness (Phase 2)Study completedNCT00463385
What this trial is testing

A Phase II Study of Pomalidomide in Myelofibrosis With Myeloid Metaplasia

Who this might be right for
Myelofibrosis With Myeloid MetaplasiaMyeloid MetaplasiaMyelofibrosis
Celgene 88
Testing effectiveness (Phase 2)Study completedNCT00669578
What this trial is testing

CC-4047 in Treating Patients With Myelofibrosis

Who this might be right for
Chronic Myeloproliferative DisordersSecondary Myelofibrosis
Mayo Clinic 77
Testing effectiveness (Phase 2)Active Not RecruitingNCT03715478
What this trial is testing

Multi-Center Study of GSK2857916 in Combination With Pomalidomide and Dex

Who this might be right for
Relapsed and/or Refractory Multiple Myeloma
Canadian Myeloma Research Group 120
Testing effectiveness (Phase 2)UnknownNCT05066607
What this trial is testing

Isatuximab Plus Pomalidomide and Dexamethasone Association for Patients With AL Amyloidosis Not in VGPR or Better After Any Previous Therapy

Who this might be right for
AL Amyloidosis
Intergroupe Francophone du Myelome 46
Large-scale testing (Phase 3)Looking for participantsNCT05730036
What this trial is testing

A Trial to Learn How Well Linvoseltamab Works Compared to the Combination of Elotuzumab, Pomalidomide and Dexamethasone for Adult Participants With Relapsed/Refractory Multiple Myeloma

Who this might be right for
Relapsed Refractory Multiple Myeloma (RRMM)
Regeneron Pharmaceuticals 410
Testing effectiveness (Phase 2)WithdrawnNCT03841565
What this trial is testing

Daratumumab, Pomalidomide, and Dexamethasone in Treating Patients With Relapsed Multiple Myeloma

Who this might be right for
Recurrent Plasma Cell Myeloma
Academic and Community Cancer Research United
Next Page